October 13, 2021
October 13, 2021 – Verzenio® (abemaciclib) is now approved as an adjuvant treatment for HR-positive, HER2-negative, node-positive early breast cancer in adults who are
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Pharmacy Benefits Management
October 12, 2021
October 12, 2021 – Teligent Pharma has recalled five lots of Lidocaine HCl Topical Solution 4%, 50mL, in a screw cap glass bottle. The affected lidocaine was found to be super
October 11, 2021
October 11, 2021 – The U.S. FDA has approved a new indication for Ocular Therapeutix’s Dextenza® (dexamethasone ophthalmic insert) to treat ocular itching associated
October 11, 2021
October 11, 2021 – Rethymic® (allogenic processed thymus tissue-agdc) has been approved as a one-time
treatment for congenital athymia in pediatric patients
October 8, 2021
October 8, 2021 – TavneosTM (avacopan – ChemoCentryx) is now U.S. FDA approved for use in adults as
an adjunct to standard therapy (including glucocorticoids)
October 5, 2021
October 5, 2021 – Tecartus® (brexucabtagene autoleucel) has received a new indication to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia in adults
October 5, 2021
October 5, 2021 – Medtronic is expanding a 2019 recall of its MiniMedTM 600 Series Insulin Pumps to include any MiniMed 600 series pump that has a clear retainer ring
October 1, 2021
October 1, 2021 – Bayer has recalled all unexpired Lotrimin® AF and Tinactin® spray products distributed between September 2018 to September 2021, with lot number beginning